Spectrophotometric microdetermination of nefopam, mebevrine and phenylpropanolamine hydrochloride in pharmaceutical formulations using alizarins

Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy

Volumn 60, Issue 8-9, 2004, Pages 1769-1774

  Shama, S A ^a   Amin, A S ^a  

^a BENHA UNIVERSITY   (Egypt)

Author keywords

Alizarins; Dosage forms; Ion pair complexes; Spectrophotometry

Indexed keywords

CALORIMETRY; CHEMICAL REACTIONS; DENSITOMETERS; DRUG PRODUCTS; ERROR ANALYSIS; GAS CHROMATOGRAPHY; MASS SPECTROMETERS; MATHEMATICAL MODELS; OPTIMIZATION;

ALIZARIN; DOSAGE FORMS; ION PAIR COMPLEXES; IONALYZERS;

SPECTROPHOTOMETRY;

ALIZARIN; ALIZARIN RED S; ALIZARINE YELLOW G; ANTHRAQUINONE DERIVATIVE; AZO COMPOUND; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; MEBEVERINE; NEFOPAM; PHENETHYLAMINE DERIVATIVE; PHENYLPROPANOLAMINE; SOLVENT;

ARTICLE; DRUG FORMULATION; METHODOLOGY; PH; SPECTROPHOTOMETRY; TEMPERATURE; TIME;

ANTHRAQUINONES; AZO COMPOUNDS; DRUG COMPOUNDING; HYDROGEN-ION CONCENTRATION; INDICATORS AND REAGENTS; NEFOPAM; PHENETHYLAMINES; PHENYLPROPANOLAMINE; SOLVENTS; SPECTROPHOTOMETRY; TEMPERATURE; TIME FACTORS;

EID: 3042715923     PISSN: 13861425     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.saa.2003.07.012     Document Type: Article

References (30)

1. Heel R.C. Drug Ther. Bull. 17:1980;59.
2. Wroe S.J. Br. Med. J. 292:1986;1672.
3. Piercy D.M. Br. Med. J. 283:1981;1508.
4. Mather G.G., Labroo R., Le Guren M.E., Lepage F., Gillardin J.M., Levy R.H. Chirality. 3:2000;153.
5. Lu B., Shi T.S. Yoown Fenxi Zazhi. 15:1995;22.
6. Lu B., Shi T.S. Yoown Fenxi Zazhi. 5:1995;54.
7. Cai R., Ye M.M., Xia C. Yoown Fenxi Zazhi. 14:1994;46.
8. Bertaccini G. Farmaco. Ed. Sci. 30:1990;823.
9. El-Wality A.F.M., Gindy A., Bedair M.F. J. Pharm. Anal. 21:1999;535.
10. Reddy M.N., Sankar D.G. Mikrochim. Acta. 126:1997;131.
11. Reddy M.N., Rao K.V.S., Sanrar D.B., Sridhar K. India Drugs. 33:1996;604.
12. Al-Deeb O., Hadiya B.M., Foda S.A. N. H. Chromotographia. 441:1997;427.
13. Tulich L.J., Rnadall J.L., Kelm B.R., Wehmeyer K.R. J. Chromatogr. B Biomed. 682:1996;273.
14. Osman E.M., Gazy A.A., Bedair M.M. Drug Dev. Ind. 21:1995;633.
15. Mueller S.M. New Engl. J. Med. 308:1983;653.
16. Zauter M.F., Gujib N., Tahboub Y., Ghanem E. J. Anal. Chem. 54:1999;1158.
17. Gil-Agusti M., Laposio J.R., Garcin-Alvariz-Coque M.C., Estervo J. J. Chromotogr. 866:2000;35.
18. Fuh M.R.S., Lu Y.T. Talanta. 48:1999;415.
19. Vinas P., Lopez Erroz C., Cerdan F.J., Cordoba M. Talanta. 47:1998;455.
20. Khanolkar D.H., Shinde V.M. India Drugs. 36:1999;438.
21. Nakahara Y., Kikura R. J. Chromotogr. B Biomed. Appl. 700:1997;83.
22. Shama S.A. J. Pharm. Biomed. Anal. 30:2002;1385.
23. Amin A.S. J. Pharm. Biomed. Anal. 29:2002;729.
24. H.T.S. Britton, Hydrogen Ions, fourth ed., Chapman & Hall, London, 1952.
25. Job P. Anal. Chim. 9:1928;113.
26. Harvey A.E., Manning D.L. J. Am. Chem. Soc. 71:1950;4488.
27. Ringbom A. Z. Anal. Chem. 115:1939;332.
28. United States Pharmacopia, Twentieth Review, The National Formulary, Ninteenth Review, The United States Pharmacopeial Convention, Rockville, MD, 2000.
29. British Pharmacopoeia, Her Majasty's, Stationary Office, London, 1998.
30. J.C. Miller, J.N. Miller, Statistics for Analytical Chemistry, third ed., Ellis Horwood, Chichester, UK, 1993.